To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. VWR will not lift restrictions for residential shipping addresses.
Specifications
- Gene ID:P09874
- Protein/peptide type:Recombinant
- Source:E. coli
- Species:Human
- Size:25 µg
- Storage conditions:Store vial at –20 °C prior to opening. Aliquot contents and freeze at –20 °C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable 2 - 3 weeks at 4 °C as an undiluted liquid. Dilute only prior to immediate use.
- Protein synonyms:PPOL|NAD(+) ADP-ribosyltransferase 1|Poly [ADP-ribose] polymerase 1|ADP-ribosyltransferase diphtheria toxin-like 1|ADPRT 1|ARTD1
- Protein/peptide name:PARP1 (N-term ZF1) Control Protein
- Purity:>90%
- Formulation:Liquid (sterile filtered)
- Shipping temperature:Dry Ice
- Tested applications:Control Protein
- Cat. no.:76221-854
Specifications
About this item
PARP1 is the primary member of the poly(ADP-ribose) polymerase family, whose function is to signal DNA damage (and to recruit repair proteins) by PARylation. PARP1 is also involved in multiple cell death pathways, including apoptosis, necroptosis, autophagy, and a relatively new pathway termed parthanatos. PARP1 can also promote tissue survival by shifting the balance of cell death programs between autophagy and necrosis. Clinical studies have shown vulnerability to PARP inhibitors in DNA repair defective cancers. PARP1-ZF is useful for researchers interested in cellular processes including DNA damage, transcriptional control, and stem cell identity research.